Anthropic warns of ‘existential risks to humanity’ from AI; AstraZeneca makes $2bn cancer drug tie-up – business live
Source:
guardianTech
September 28, 2026 · 23:48
From the publisher
Rolling coverage of the latest economic and financial newsPharmaceuticals news: AstraZeneca is investing $2bn in biopharmaceutical oncology company Summit Therapeutics, as part of a tie-up to jointly develop and test anti-cancer drugs.Announcing the deal, AstraZeneca says the two companies will collaborate on a series of studies testing their cancer treatments together.“A core pillar of our oncology strategy is to broaden the reach of our ADC portfolio as the backbone of treatment across tumour types with combinations alongside next-generation immunotherapies.Bispecifics targeting PD-1 and VEGF are rapidly advancing in development and have the potential to improve on current immunotherapies, particularly in lung, breast and gastrointestinal cancers. This opportunity to combine ivonescimab…
The original article opens on the publisher's website.
More from Automotive
View topic →Japan's economy unexpectedly contracts in third-quarter as elevated energy costs bite
cnbc
Nov 15, 2026 · 16:11
Is bad news for Jensen Huang also bad news for the AI industry?
techcrunch
Nov 15, 2026 · 13:56
TechCrunch Mobility: The Nvidia backup plan for China’s self-driving industry
techcrunch
Nov 15, 2026 · 09:05
‘Grand Theft Auto Flu’: is the whole world really taking the day off work to play GTA VI?
guardianTech
Nov 15, 2026 · 06:00
Rivian, Lucid, Scout CEOs aren’t counting on Democrats to restore EV federal support after midterm wins
cnbc
Nov 15, 2026 · 05:00